Letters Section Editor: Stephen J. Lurie,
MD, PhD, Senior Editor.
To the Editor: Dr McCormick and colleagues1 underscore the limitations of voluntary public
disclosure of performance data. However, I would not call voluntary public
disclosure a complete failure, given this revelation of its attendant gaming
and manipulations. The article buttresses the potential and ongoing trade-offs
between market dynamics (in principle driven by costs and quality2) and the quality movement in the United States
and other industrialized nations with managed care. Thus, there is need to
reconcile corporate governance and clinical governance: this may entail reengineering
the entire system around the empowered health care consumer.
Arah OA. Public Disclosure of Health Plan Quality of CarePublic Disclosure of Health Plan Quality of Care. JAMA. 2003;289(7):845-847. doi:10.1001/jama.289.7.845-a